Table 5:
Multivariable-adjusted risk of mortality subtypes by total flavonoid and flavonoid class, comparing participants in the lowest quintile of flavonoid intake (referent group) to those in the highest quintile.1
Cancer mortality3 | CVD mortality4 | Other-cause5 | |
---|---|---|---|
Quintile 5 | Quintile 5 | Quintile 5 | |
Total flavonoid intake | |||
Age-adjusted | 0.80 (0.64–0.98) | 0.66 (0.43–1.02) | 0.86 (0.71–1.05) |
Multivariable-adjusted2 | 0.84 (0.67–1.04) | 0.83 (0.53–1.29) | 1.03 (0.84–1.26) |
Flavonol intake | |||
Age-adjusted | 0.98 (0.80–1.20) | 0.76 (0.50–1.16) | 1.08 (0.88–1.31) |
Multivariable-adjusted2 | 0.99 (0.80–1.24) | 0.91 (0.58–1.41) | 1.22 (0.99–1.51) |
Flavan-3-ol intake | |||
Age-adjusted | 0.84 (0.68–1.04) | 0.64 (0.42–0.98) | 0.85 (0.70–1.04) |
Multivariable-adjusted2 | 0.87 (0.70–1.08) | 0.75 (0.49–1.16) | 0.96 (0.78–1.17) |
Proanthcyanin intake | |||
Age-adjusted | 0.86 (0.70–1.06) | 0.64 (0.41–0.99) | 0.83 (0.68–1.00) |
Multivariable-adjusted2 | 0.90 (0.72–1.11) | 0.77 (0.49–1.20) | 0.97 (0.79–1.18) |
Flavone intake | |||
Age-adjusted | 0.89 (0.72–1.10) | 0.74 (0.48–1.16) | 0.91 (0.75–1.12) |
Multivariable-adjusted2 | 1.00 (0.80–1.06) | 1.15 (0.72–1.83) | 1.22 (0.99–1.51) |
Flavanone intake | |||
Age-adjusted | 0.91 (0.73–1.13) | 0.81 (0.51–1.28) | 0.95 (0.77–1.18) |
Multivariable-adjusted2 | 1.03 (0.83–1.29) | 1.10 (0.69–1.76) | 1.21 (0.97–1.50) |
Anthocyanin intake | |||
Age-adjusted | 0.74 (0.59–0.91) | 0.48 (0.30–0.78) | 0.74 (0.61–0.90) |
Multivariable-adjusted2 | 0.77 (0.61–0.98) | 0.85 (0.50–1.43) | 1.10 (0.88–1.37) |
Results are HR (95% CI) and n(%) where appropriate. n = 93,145).
Multivariable adjusted model includes: age, body mass index, smoking status, menopausal status, family history of diabetes, cancer and myocardial infarction, multivitamin supplement use, Aspirin use, race, type 2 diabetes, hypercholesterolemia, hypertension, physical activity, caloric intake, alcohol consumption and the Alternative Health Eating Index (minus alcohol) score.
Total number of cancer mortalities: 887.
Total number of cardiovascular disease (CVD) mortalities: 189.
Total number of mortalities from other causes: 818